258 related articles for article (PubMed ID: 5770150)
1. Effects of isoproterenol on hemodynamic alterations, myocardial metabolism, and coronary flow in experimental acute myocardial infarction with shock.
Kuhn LA; Kline HJ; Goodman P; Johnson CD; Marano AJ
Am Heart J; 1969 Jun; 77(6):772-83. PubMed ID: 5770150
[No Abstract] [Full Text] [Related]
2. Effect of isoproterenol and norepinephrine on myocardial function in experimental cardiogenic shock.
Cronin RF
Am Heart J; 1967 Sep; 74(3):387-95. PubMed ID: 6041067
[No Abstract] [Full Text] [Related]
3. Effects of isoproterenol and 1-norepinephrine on function, coronary flow, and oxygen consumption of the intact left ventricle.
Abe T; Malik AB; O'Kane HO; Geha AS
Surgery; 1973 Oct; 74(4):562-9. PubMed ID: 4729221
[No Abstract] [Full Text] [Related]
4. The effect of beta-adrenergic blockade on myocardial haemodynamics and metabolism during light halothane anaesthesia.
Merin RG; Tonnesen AS
Can Anaesth Soc J; 1969 Jul; 16(4):336-44. PubMed ID: 5807476
[No Abstract] [Full Text] [Related]
5. Anaerobiosis induced by isoproterenol and glucagon in the presence of restricted coronary inflow.
Shaver JC; Lombardo AA; Shaver VC
Am Heart J; 1974 Jan; 87(1):97-104. PubMed ID: 4808764
[No Abstract] [Full Text] [Related]
6. Systemic and coronary hemodynamic effects of glucagon.
Rowe GG
Am J Cardiol; 1970 Jun; 25(6):670-4. PubMed ID: 5420906
[No Abstract] [Full Text] [Related]
7. Experimental myocardial infarction. X. Efficacy of glucagon in acute and healing phase in intact conscious dogs: effects on hemodynamics and myocardial oxygen consumption.
Kumar R; Molokhia FA; Norman JC; Inamdar AN; Messer JV; Abelmann WH; Hood WB; Sharma GV
Circulation; 1972 Jan; 45(1):55-64. PubMed ID: 5007038
[No Abstract] [Full Text] [Related]
8. Hemodynamic effects of isoproterenol infusion. An experimental study of cardiac performance with special emphasis on coronary artery flow dynamics.
Dedichen H; Schenk WG
Arch Surg; 1968 Dec; 97(6):934-9. PubMed ID: 5727695
[No Abstract] [Full Text] [Related]
9. Systemic and coronary hemodynamic effects of isoproterenol in control animals and those pretreated with a MAO inhibitor (pargyline hydrochloride).
McKenna DH; Afonso S; Jaramillo CV; Crumpton CW; Rowe GG
Arch Int Pharmacodyn Ther; 1966 Aug; 162(2):275-82. PubMed ID: 5968511
[No Abstract] [Full Text] [Related]
10. Effect of isoproterenol on ventricular work and myocardial metabolism in the postoperative heart.
Mueller H; Giannelli S; Ayres SM; Conklin EF; Gregory JJ
Circulation; 1968 Apr; 37(4 Suppl):II146-53. PubMed ID: 5646574
[No Abstract] [Full Text] [Related]
11. Hemodynamic and metabolic effects of hyperbaric oxygenation in myocardial infarction.
Kline HJ; Marano AJ; Johnson CD; Goodman P; Jacobson JH; Kuhn LA
J Appl Physiol; 1970 Mar; 28(3):256-63. PubMed ID: 5414754
[No Abstract] [Full Text] [Related]
12. Effects of perhexiline on coronary hemodynamic and myocardial metabolic responses to tachycardia.
Pepine CJ; Schang SJ; Bemiller CR
Circulation; 1974 May; 49(5):887-93. PubMed ID: 4828610
[No Abstract] [Full Text] [Related]
13. Cardiovascular pharmacology of quazodine (MJ-1988), with particular reference to effects of myocardial blood flow and metabolic heat production.
Parratt JR; Winslow E
Br J Pharmacol; 1971 Jun; 42(2):193-204. PubMed ID: 4397441
[TBL] [Abstract][Full Text] [Related]
14. Propranolol in the treatment of acute myocardial infarction. Effect on myocardial oxygenation and hemodynamics.
Mueller HS; Ayres SM; Religa A; Evans RG
Circulation; 1974 Jun; 49(6):1078-87. PubMed ID: 4598632
[No Abstract] [Full Text] [Related]
15. Effects of cardiac tamponade on myocardial performance, blood flow, and metabolism.
Frank MJ; Nadimi M; Lesniak LJ; Hilmi KI; Levinson GE
Am J Physiol; 1971 Jan; 220(1):179-85. PubMed ID: 5538649
[No Abstract] [Full Text] [Related]
16. Effect of isoproterenol,l-norepinephrine, and intraaortic counterpulsation on hemodynamics and myocardial metabolism in shock following acute myocardial infarction.
Mueller H; Ayres SM; Giannelli S; Conklin EF; Mazzara JT; Grace WJ
Circulation; 1972 Feb; 45(2):335-51. PubMed ID: 5009478
[No Abstract] [Full Text] [Related]
17. Effects of endotoxin on myocardial hemodynamics, performance, and metabolism during beta adrenergic blockade.
Hinshaw LB; Greenfeild LJ; Archer LT; Guenter CA
Proc Soc Exp Biol Med; 1971 Sep; 137(4):1217-24. PubMed ID: 4400322
[No Abstract] [Full Text] [Related]
18. The systemic and coronary hemodynamic effects of lidoflazine.
Thomsen JH; Stenlund RR; Corliss RJ; Sialer S; Rowe GG
Arch Int Pharmacodyn Ther; 1968 Mar; 172(1):15-23. PubMed ID: 5650324
[No Abstract] [Full Text] [Related]
19. [Clinical trial of the new coronary dilator hexobendine].
Henke C; Dudik E; Steim H
Arzneimittelforschung; 1968 Aug; 18(8):1103-7. PubMed ID: 4885101
[No Abstract] [Full Text] [Related]
20. Regional blood flow of myocardium and other rat tissues after isoproterenol administration.
Kapitola J; Kölbel F; Schüllerová M; Schreiberová O
Physiol Bohemoslov; 1973; 22(2):137-42. PubMed ID: 4272873
[No Abstract] [Full Text] [Related]
[Next] [New Search]
